EMJ Neurology 8 [Supplement 2] . 2020

In this issue

In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored the sphingosine 1-phosphate (S1P) receptor modulators drug class and how they can be utilised in the management of patients with MS.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.